Stoke Therapeutics Investor Relations Material
Latest events
Status Update
Stoke Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Stoke Therapeutics Inc
Access all reports
Stoke Therapeutics Inc. is a biotechnology firm focused on innovative treatments for severe genetic diseases by enhancing protein expression through RNA-based medicines. The company leverages its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) technology to develop antisense oligonucleotides (ASOs) aimed at selectively restoring protein levels. This approach is particularly geared towards addressing diseases caused by haploinsufficiencies, where a loss of about 50% of normal protein levels leads to illness. The company is headquartered in Bedford, Massachusetts, and its shares are listed on the Nasdaq.
Key slides for Stoke Therapeutics Inc
Status Update
Stoke Therapeutics Inc
Status Update
Stoke Therapeutics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
STOK
Country
🇺🇸 United States